CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-23 | Fenimore Christopher R. SVP Controller | Option exercise | +5,000 | $555.67 | $2.8M | 21,860 |
| 2024-01-23 | Fenimore Christopher R. SVP Controller | Shares withheld for taxes | −3,986 | $948.50 | $3.8M | 17,874 |
| 2024-01-23 | Fenimore Christopher R. SVP Controller | Option exercise | +5,000 | $399.66 | $2.0M | 22,874 |
| 2024-01-23 | Fenimore Christopher R. SVP Controller | Shares withheld for taxes | −3,583 | $948.50 | $3.4M | 19,291 |
| 2024-01-23 | Fenimore Christopher R. SVP Controller | Option exercise · Non-Qualified Stock Option (right to buy) | −5,000 | 0 | ||
| 2024-01-23 | Fenimore Christopher R. SVP Controller | Option exercise · Non-Qualified Stock Option (right to buy) | −5,000 | 0 | ||
| 2024-01-23 | Landry Robert E EVP Finance CFO | Option exercise | +1,100 | $378.98 | $417K | 24,084 |
| 2024-01-23 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −776 | $948.50 | $736K | 23,308 |
| 2024-01-23 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −1,100 | 13,087 | ||
| 2024-01-17 | Landry Robert E EVP Finance CFO | Option exercise | +500 | $378.98 | $189K | 23,338 |
| 2024-01-17 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −354 | $932.34 | $330K | 22,984 |
| 2024-01-17 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −500 | 14,187 | ||
| 2024-01-12 | Landry Robert E EVP Finance CFO | Option exercise | +800 | $378.98 | $303K | 23,406 |
| 2024-01-12 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −568 | $928.18 | $527K | 22,838 |
| 2024-01-12 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −800 | 14,687 | ||
| 2024-01-04 | Landry Robert E EVP Finance CFO | Option exercise | +500 | $378.98 | $189K | 22,948 |
| 2024-01-04 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −342 | $917.05 | $314K | 22,606 |
| 2024-01-04 | Landry Robert E EVP Finance CFO | Option exercise · Non-Qualified Stock Option (right to buy) | −500 | 15,487 | ||
| 2024-01-03 | Bassler Bonnie L Director | Option exercise 10b5-1 | +826 | $380.95 | $315K | 2,208 |
| 2024-01-03 | Bassler Bonnie L Director | Sale 10b5-1 | −826 | $914.00 | $755K | 1,382 |
Page 39 of 49 · 971 trades